ScienceDex / Researcher record
Krupnick, Alexander S.
- Courier Therapeutics, Inc. (no department on record)
From the FY2018 NIH awards this investigator leads as contact PI. The department is the award's.
NIH Funding · FY2018
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2008 | $120,606 | 1 | #35,440 |
| 2009 | $228,606 | 2 | #32,034 |
| 2010 | $120,606 | 1 | #39,529 |
| 2011 | $120,606 | 1 | #36,930 |
| 2012 | $119,913 | 1 | #36,866 |
| 2018 | $288,105 | 1 | #29,484 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20081 record
- FY20092 records
- FY20101 record
- FY20111 record
- FY20121 record
- FY2018 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2018Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2018 award records by amount
NIH award records listing Krupnick, Alexander S. as a PI. Multi-PI records show the full award amount for context.
- 1R41CA224520-01A1R41Contact PINovel Immuno-oncology Strategy for Targeted Cytotoxic Lymphocyte Activation$288.1Kaward amount
Award organization
Organizations that administered FY2018 awards listing Krupnick, Alexander S. as a PI.
FY2018 award administered by Courier Therapeutics, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardCourier Therapeutics, Inc.
- 2011$500K Cumulative Funding